Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis


Creative Commons License

Canan H., SIZMAZ S., Altan-Yaycioglu R., Sariturk C., Yilmaz G.

CLINICAL INTERVENTIONS IN AGING, cilt.9, ss.141-145, 2014 (SCI-Expanded) identifier identifier identifier

Özet

Purpose: To describe 1-year clinical results of intravitreal ranibizumab treatment in patients with choroidal neovascularization secondary to exudative age-related macular degeneration (AMD) and to evaluate whether early treatment is a predictive value for prognosis of the disease.